Vanguard Group »

Leap Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 410k 4.15
2023-09-30 $462k 335k 1.38
2023-06-30 $1.0M 327k 3.13